ACETAMINOPHEN TABLETS USP 500 MG 500 MG
ACETAMINOPHEN : 500 MG · DIN 02362244 · APOTEX INC
Health Canada status: MARKETED
What is ACETAMINOPHEN TABLETS USP 500 MG?
ACETAMINOPHEN TABLETS USP 500 MG 500 MG contains ACETAMINOPHEN : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02362244, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 26-Sep-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02362244 |
|---|---|
| Brand name | ACETAMINOPHEN TABLETS USP 500 MG |
| Generic / active ingredient | ACETAMINOPHEN : 500 MG |
| Manufacturer | APOTEX INC |
| Strength | 500 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | N02BE01 ACETAMINOPHEN (PARACETAMOL) |
| AHFS class | 28:08.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 26-Sep-2011 |
| Original market date | 2011-09-26 00:00:00 |
Is ACETAMINOPHEN (PARACETAMOL) in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by APOTEX INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N02BE01 ACETAMINOPHEN (PARACETAMOL). 75 of 409 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACET 120 | 120 MG | SUPPOSITORY | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02230434 |
| ACET 160 | 160 MG | SUPPOSITORY | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02230435 |
| ACET 325 | 325 MG | SUPPOSITORY | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02230436 |
| ACET 650 | 650 MG | SUPPOSITORY | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02230437 |
| ACETAMINOPHEN 160 MG CHEWABLE TABLETS | 160 MG | TABLET (CHEWABLE) | LABORATOIRES TRIANON INC. | MARKETED | DIN 02237562 |
| ACETAMINOPHEN 325MG TABLETS REGULAR STRENGTH | 325 MG | TABLET | CELLCHEM PHARMACEUTICALS INC. | MARKETED | DIN 02252805 |
| ACETAMINOPHEN 500 MG TABLETS EXTRA STRENGTH EASY TO SWALLOW | 500 MG | TABLET | CELLCHEM PHARMACEUTICALS INC. | MARKETED | DIN 02255251 |
| ACETAMINOPHEN 500MG TABLETS EXTRA STRENGTH | 500 MG | TABLET | CELLCHEM PHARMACEUTICALS INC. | MARKETED | DIN 02252813 |
| ACETAMINOPHEN ARTHRITIS PAIN | 650 MG | TABLET (EXTENDED-RELEASE) | PERRIGO INTERNATIONAL | MARKETED | DIN 02272482 |
| ACETAMINOPHEN CAPLETS 325 MG | 325 MG | TABLET | LABORATOIRES TRIANON INC. | MARKETED | DIN 01977415 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.